Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
171.6 EUR | +0.12% | +0.20% | +19.71% |
06-11 | Merck KGaA to Build EUR62 Million Facility for Life Science Business | MT |
06-07 | Health Care Up as Defensive Rotation Continues - Health Care Roundup | DJ |
Chart calendar Merck KGaA
Upcoming events on Merck KGaA
Past events on Merck KGaA
2024-06-03 14:30 | American Society of Clinical Oncology Meeting - Abstract No - 8575 |
2024-06-03 11:12 | American Society of Clinical Oncology Meeting - Abstract No - 4508 |
2024-06-03 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 3018 |
2024-06-03 09:00 | R&D Day |
2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 4567 |
2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 4566 |
2024-06-02 10:00 | American Society of Clinical Oncology Meeting - Abstract No - TPS6126 |
2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No - LBA3559 |
2024-06-01 14:30 | American Society of Clinical Oncology Meeting - Abstract No - 3550 |
2024-06-01 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 2614 |
2024-06-01 10:00 | American Society of Clinical Oncology Meeting - Abstract No - 2612 |
2024-06-01 04:00 | American Society of Clinical Oncology Meeting - Abstract No - 3000 |
2024-05-30 | American Society of Clinical Oncology Meeting - Abstract No - e18039 |
2024-05-15 08:00 | Q1 2024 Earnings Call |
2024-05-15 01:00 | Q1 2024 Earnings Release |
2024-04-28 | Détachement de for final dividend |
2024-04-26 04:00 | Annual General Meeting |
2024-03-07 08:00 | Q4 2023 Earnings Call |
2024-03-07 01:00 | Q4 2023 Earnings Release |
2024-01-08 12:00 | JPMorgan Healthcare Conference |
Past dividends on Merck KGaA
2024-04-28 | Annual 2.2 EUR |
2023-05-01 | Annual 2.2 EUR |
2022-04-24 | Annual 1.85 EUR |
2021-04-25 | Annual 1.4 EUR |
2020-05-28 | Annual 1.3 EUR |
2019-04-28 | Annual 1.25 EUR |
2018-04-29 | Annual 1.25 EUR |
2017-05-01 | Annual 1.2 EUR |
2016-05-01 | Annual 1.05 EUR |
2015-04-19 | Annual 1 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 16 152 16 092 0.37% | 17 534 17 407 0.73% | 19 687 19 632 0.28% | 22 232 22 259 -0.12% | 20 993 21 026 -0.16% | 21 324 |
EBITDA Million EUR | Released Forecast Spread | 4 385 4 335 1.15% | 5 201 5 081 2.36% | 6 103 6 096 0.12% | 6 849 6 898 -0.71% | 5 879 5 823 0.97% | 5 964 |
EBIT Million EUR | Released Forecast Spread | 2 120 2 262 -6.29% | 2 985 2 985 -0.01% | 4 179 4 150 0.69% | 4 474 4 933 -9.29% | 3 609 3 730 -3.24% | 4 033 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 735 1 928 -9.99% | 2 630 2 726 -3.52% | 3 924 3 886 0.97% | 4 287 4 727 -9.3% | 3 484 3 695 -5.72% | 3 817 |
Net income Million EUR | Released Forecast Spread | 1 320 1 448 -8.85% | 1 987 1 999 -0.57% | 3 055 2 986 2.3% | 3 326 3 674 -9.48% | 2 824 2 831 -0.26% | 2 997 |
EPS EUR | Released Forecast Spread | 3,04 3,36 -9.47% | 4,57 4,62 -1.11% | 7,03 6,89 2.1% | 7,65 8,46 -9.54% | 6,49 6,50 -0.22% | 6,88 |
Announcement Date | 05/03/20 | 04/03/21 | 03/03/22 | 02/03/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 8 489 8 553 -0.75% | 5 198 5 218 -0.38% | 5 568 5 417 2.79% | 5 806 5 695 1.95% | 5 660 5 698 -0.66% | 5 293 5 254 0.73% | 5 302 5 221 1.55% | 5 173 5 255 -1.56% | 5 225 5 248 -0.44% | 5 120 5 144 -0.47% | 5 262 | 5 415 | 5 547 |
EBITDA Million EUR | Released Forecast Spread | 2 256 2 232 1.06% | 1 629 1 631 -0.15% | 1 782 1 709 4.27% | 1 811 1 795 0.85% | 1 628 1 658 -1.83% | 1 587 1 550 2.41% | 1 553 1 511 2.76% | 1 446 1 369 5.66% | 1 293 1 256 2.95% | 1 454 1 354 7.38% | 1 428 | 1 513 | 1 695 |
EBIT Million EUR | Released Forecast Spread | 1 173 1 198 -2.07% | 1 177 1 248 -5.66% | 1 234 1 319 -6.45% | 890 1 241 -28.29% | 1 035 1 124 -7.95% | 969 1 028 -5.7% | 983 903 8.89% | 621 750 -17.18% | 931 815 14.21% | 833 | 1 078 | 1 086 | |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 139 1 131 0.74% | 1 122 1 207 -7.05% | 1 187 1 266 -6.26% | 839 1 202 -30.19% | 1 012 1 088 -7.01% | 894 981 -8.88% | 937 850 10.29% | 641 839 -23.56% | 899 785 14.55% | 807 | 1 053 | 1 063 | |
Net income Million EUR | Released Forecast Spread | 880 880 0.02% | 867 931 -6.86% | 923 980 -5.76% | 655 967 -32.26% | 796 825 -3.53% | 704 765 -8% | 739 658 12.37% | 586 647 -9.4% | 694 657 5.6% | 699 | 824 | 875 | |
EPS EUR | Released Forecast Spread | 1,72 1,86 -7.53% | 2,02 2,02 -0.16% | 1,99 2,13 -6.65% | 2,12 2,27 -6.43% | 1,51 2,22 -32.06% | 1,83 1,90 -3.6% | 1,62 1,76 -8.06% | 1,70 1,54 10.21% | 1,34 1,50 -10.42% | 1,60 1,52 5.02% | 1,60 | 1,91 | 2,02 |
Announcement Date | 06/08/20 | 12/05/22 | 04/08/22 | 10/11/22 | 02/03/23 | 11/05/23 | 03/08/23 | 09/11/23 | 07/03/24 | 15/05/24 | - | - | - |
Past sector events for Merck KGaA
2024-05-23 01:00 | CALLIDITAS THERAPEUTICS AB: Q1 2024 Earnings Release |
2024-05-15 01:00 | MERCK KGAA: Q1 2024 Earnings Release |
2024-05-13 | OSCOTEC INC.: Q1 2024 Earnings Release |
2024-05-13 | MEZZION PHARMA CO.,LTD.: Q1 2024 Earnings Release |
2024-05-08 | SK BIOPHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
2024-05-08 16:05 | SUPERNUS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-06 | KISSEI PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-05-06 | KYOWA KIRIN CO. LTD.: Q1 2024 Earnings Release |
2024-04-29 | YOUCARE PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release |
2024-04-29 | HK INNO.N CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- MRK Stock
- Calendar Merck KGaA